Cargando…
Proteomic analysis of pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a rare but fatal cardiovascular disorder with high morbidity and mortality. Diagnosis and treatment of this disease at an early stage would greatly improve outcomes. The molecular indicators of PAH are mostly nonspecific, and diagnostic and prognostic biomark...
Autores principales: | Qin, Xiaohan, Li, Tianhao, Sun, Wei, Guo, Xiaoxiao, Fang, Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482352/ https://www.ncbi.nlm.nih.gov/pubmed/34729151 http://dx.doi.org/10.1177/20406223211047304 |
Ejemplares similares
-
Proteomic and Metabolomic Analyses of Right Ventricular Failure due to Pulmonary Arterial Hypertension
por: Qin, Xiaohan, et al.
Publicado: (2022) -
Right Ventricle to Pulmonary Artery Coupling Predicts the Risk Stratification in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
por: Lai, Jinzhi, et al.
Publicado: (2022) -
Effect of Sacubitril/Valsartan on the Right Ventricular Function and Pulmonary Hypertension in Patients With Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta‐Analysis of Observational Studies
por: Zhang, Jing, et al.
Publicado: (2022) -
Plasma Proteomic Study in Pulmonary Arterial Hypertension Associated with Congenital Heart Diseases
por: Zhang, Xi, et al.
Publicado: (2016) -
Integrative proteomics and phosphoproteomics in pulmonary arterial hypertension
por: Xu, Weiling, et al.
Publicado: (2019)